Cytotoxic T cell adoptive immunotherapy as a treatment for nasopharyngeal carcinoma.
View/ Open
File version
Version of Record (VoR)
Author(s)
Lutzky, Viviana P
Crooks, Paulina
Morrison, Leanne
Stevens, Natasha
Davis, Joanne E
Corban, Monika
Hall, David
Panizza, Benedict
Coman, William B.
Coman, Scott
Moss, Denis J
Griffith University Author(s)
Year published
2014
Metadata
Show full item recordAbstract
Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC). We assess the safety and tolerability of adoptive transfer of autologous cytotoxic T lymphocytes (CTLs) specific for the EBV latent membrane protein (LMP) in a patient with recurrent NPC. After infusion, the majority of pulmonary lesioEpstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC). We assess the safety and tolerability of adoptive transfer of autologous cytotoxic T lymphocytes (CTLs) specific for the EBV latent membrane protein (LMP) in a patient with recurrent NPC. After infusion, the majority of pulmonary lesio
View less >
View less >
Journal Title
Clinical and Vaccine Immunology
Volume
21
Issue
2
Copyright Statement
© 2014 American Society for Microbiology. The attached file is reproduced here in accordance with the copyright policy of the publisher. Please refer to the journal's website for access to the definitive, published version.
Subject
Medical and Health Sciences not elsewhere classified
Immunology